183 related articles for article (PubMed ID: 36804623)
21. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
[TBL] [Abstract][Full Text] [Related]
22. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
[TBL] [Abstract][Full Text] [Related]
23. Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
Holm J; Gerke O; Vilstrup MH; Spasojevic D; Sponholtz SE; Jochumsen KM; Thomassen A; Hildebrandt MG; Jensen PT
Gynecol Oncol; 2022 Nov; 167(2):152-158. PubMed ID: 36182533
[TBL] [Abstract][Full Text] [Related]
24. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008217. PubMed ID: 23543561
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of the 2018 FIGO staging system for cervical cancer.
Mohamud A; Høgdall C; Schnack T
Gynecol Oncol; 2022 Jun; 165(3):506-513. PubMed ID: 35346512
[TBL] [Abstract][Full Text] [Related]
26. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
[TBL] [Abstract][Full Text] [Related]
27. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
28. Retrospective study of pelvic and para-aortic lymph nodes positivity in stage 1A to 2A cervical cancer patients.
John Lim BB; Yong CM
Med J Malaysia; 2021 Jul; 76(4):534-540. PubMed ID: 34305115
[TBL] [Abstract][Full Text] [Related]
29. Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.
Qin F; Pang H; Yu T; Luo Y; Dong Y
Technol Cancer Res Treat; 2022; 21():15330338221086403. PubMed ID: 35341413
[TBL] [Abstract][Full Text] [Related]
30. Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy.
Loverix L; Salihi RR; Van Nieuwenhuysen E; Concin N; Han S; van Gorp T; Vergote I
Int J Gynecol Cancer; 2020 Apr; 30(4):466-472. PubMed ID: 32079714
[TBL] [Abstract][Full Text] [Related]
31. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
Wang R; Tao X; Wu X; Jiang H; Xia H
J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
[TBL] [Abstract][Full Text] [Related]
32. [Outcomes and prognosis of radical surgery in patients with stageⅠb2 and Ⅱa2 cervical squamous cell carcinoma].
Zhou F; Chen F; Pan T; Zhu T; Zhang YL; Zhang P; Tang HR
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):361-369. PubMed ID: 35658327
[No Abstract] [Full Text] [Related]
33. Significance of para-aortic lymph node evaluation in patients with FIGO IIIC1 cervical cancer.
Cho WK; Kim YJ; Kim H; Kim YS; Park W
Jpn J Clin Oncol; 2020 Sep; 50(10):1150-1156. PubMed ID: 32577748
[TBL] [Abstract][Full Text] [Related]
34. Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma.
Fastrez M; Goffin F; Vergote I; Vandromme J; Petit P; Leunen K; Degueldre M
Acta Obstet Gynecol Scand; 2013 Aug; 92(8):895-901. PubMed ID: 23590725
[TBL] [Abstract][Full Text] [Related]
35. Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer.
Lee JM; Lee KB; Lee SK; Park CY
J Obstet Gynaecol Res; 2007 Jun; 33(3):288-93. PubMed ID: 17578357
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic Debulking of Enlarged Pelvic Nodes during Surgical Para-aortic Staging in Locally Advanced Cervical Cancer: A Retrospective Comparative Cohort Study.
Díaz-Feijoo B; Acosta Ú; Torné A; Gil-Ibáñez B; Hernández A; Domingo S; Gil-Moreno A;
J Minim Invasive Gynecol; 2022 Jan; 29(1):103-113. PubMed ID: 34217852
[TBL] [Abstract][Full Text] [Related]
37. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
[TBL] [Abstract][Full Text] [Related]
38. Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation.
Nasioudis D; Rush M; Taunk NK; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Kim SH; Latif NA
Int J Gynecol Cancer; 2022 Jul; 32(7):823-827. PubMed ID: 35788115
[TBL] [Abstract][Full Text] [Related]
39. Laparoscopic lymphadenectomy in advanced cervical cancer: prognostic and therapeutic value.
Del Pino M; Fusté P; Pahisa J; Rovirosa A; Martínez-Serrano MJ; Martínez-Román S; Alonso I; Vidal L; Ordi J; Torné A
Int J Gynecol Cancer; 2013 Nov; 23(9):1675-83. PubMed ID: 24172103
[TBL] [Abstract][Full Text] [Related]
40. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.
Lea JS; Sheets EE; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2002 Feb; 84(2):285-8. PubMed ID: 11812088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
